SARS-CoV-2 Persistent Viral Shedding in the Context of Hydroxychloroquine-Azithromycin Treatment

Abstract

SARS-CoV-2 nasopharyngeal shedding contributes to the spread of the COVID-19 epidemic. Among 3271 COVID-19 patients treated at the Hospital University Institute Méditerranée Infection, Marseille, France from 3 March to 27 April 2020, tested at least twice by qRT-PCR, the median SARS-CoV-2 nasopharyngeal shedding duration was 6 days (range 2–54 days). Compared with short shedders (qRT-PCR positivity < 10 days), 34 (1.04%) persistent shedders (qRT-PCR positivity ≥ 17 days; mean ± SD: 23.3 ± 3.8 days) were significantly older, with associated comorbidities, exhibiting lymphopenia, eosinopenia, increased D-dimer and increased troponin (p < 0.05), and were hospitalized in intensive care unit in 17.7% vs. 1.1% of cases (p < 0.0001). Viral culture was positive in six persistent shedders after day 10, including in one patient after day 17, and no viral co-pathogen was detected in 33 tested patients. Persistent shedders received azithromycin plus hydroxychloroquine ≥ 3 days in 26/34 (76.5%) patients, a figure significantly lower than in short shedders (86.6%) (p = 0.042). Accordingly, mortality was 14.7% vs. 0.5% (p < 0.0001). Persistent shedding was significantly associated with persistent dyspnea and anosmia/ageusia (p < 0.05). In the context of COVID-19 treatment, including treatment with azithromycin plus hydroxychloroquine, the persistence of SARS-CoV-2 nasopharyngeal shedding was a rare event, most frequently encountered in elderly patients with comorbidities and lacking azithromycin plus hydroxychloroquine treatment.

SARS-CoV-2, CT-Values, and Infectivity—Conclusions to Be Drawn from Side Observations

“…In their recent article published in Viruses, Michel Drancourt and colleagues [ 1 ] have made an interesting but underestimated side-observation. As shown in Figure 1 , they were able to isolate infectious SARS-CoV-2 virus from a clinical sample with a low concentration of viral RNA, which is reflected by a PCR Ct-value of 33.…”

Evaluation of the performance of a rapid antigen test (Roche) for COVID‐19 diagnosis in an emergency setting in Sweden

“…17 However, there are also data about successful isolation of infectious virus in samples up to 1-2 months during follow-up. [18][19][20] In one study, the authors demonstrated a better correlation between an Ag-RDT and culture positivity than between rRT-PCR and culture positivity; therefore, an Ag-RDT might be better suited to determining potential infectivity. 21 The main advantage of using an Ag-RDT compared to rRT-PCR is that an Ag-RDT provides a fast result and detects most of the samples with higher viral load.…”

A Possible Role of Remdesivir and Plasma Therapy in the Selective Sweep and Emergence of New SARS-CoV-2 Variants

“…The elderly might be at greater risk for prolonged viral shedding due to their weakened immune system. However, viral persistence was significantly associated with older age in some studies [ 15 , 16 ] but not in others [ 17 , 18 , 19 ]. Extended viral carriage is theoretically prone to the emergence of viral mutants in the case of antiviral therapies, as is observed for HIV infection.…”